Advance Search
GAO Hang, LIU Chunying. Research progress of microbes of urinary tract and urinary tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 128-132. DOI: 10.7619/jcmp.202023039
Citation: GAO Hang, LIU Chunying. Research progress of microbes of urinary tract and urinary tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 128-132. DOI: 10.7619/jcmp.202023039
shu

Research progress of microbes of urinary tract and urinary tract infection

  • 1. First College of Clinical Medicine of Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, 712046;

  • 2. Second Department of Nephrology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, 712000

More Information
  • Received Date: September 25, 2020
  • Available Online: December 20, 2020
    Graphical Abstract
    • Abstract
  • Resident microbial communities exist in urinary tract of humanity. However, the relationship between the urological microbiome and the host as well as the basic biological principles have not been elucidated in clinical practice. A detailed understanding of the pathogenesis of urinary tract infection(UTI)is the key to the clinical development of novel antimicrobial agents for the effective treatment of UTI. Through the study of metabolomics and gene expression, people began to understand the dynamic regulation of bacterial virulence throughout the infectious cycle, so as to accurately confirm the determinant factors of bacterial virulence. At present, some progress has been made in the study of human microbiome, and the review expected to provide references for the development of new UTI therapies, thus improving the quality of life of patients.
    • FullText(HTML)
    • References (57)
  • ÖZTÜRK R, MURT A. Epidemiology of urological infections: a global burden[J]. World J Urol, 2020, 38(11): 2669-2679.
    FLORES-MIRELES A L, WALKER J N, CAPARON M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options[J]. Nat Rev Microbiol, 2015, 13(5): 269-284.
    FOXMAN B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden [J]. Infect Dis Clin North Am, 2014, 28(1): 1-14.
    Consortium The Human Microbiome Project. Structure, function and diversity of the healthy human microbiome[J]. Nature, 2012, 486(7402): 207-214.
    LLOYD-PRICE J, MAHURKAR A, RAHNAVARD G, et al. Erratum: Strains, functions and dynamics in the expanded Human Microbiome Project[J]. Nature, 2017, 551(7679): 256.
    Consortium The Human Microbiome Project. A framework for human microbiome research[J]. Nature, 2012, 486(7402): 215-221.
    HILT E E, MCKINLEY K, PEARCE M M, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder[J]. J Clin Microbiol, 2014, 52(3): 871-876.
    SIDDIQUI H, NEDERBRAGT A J, LAGESEN K, et al. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons[J]. BMC Microbiol, 2011, 11: 244.
    BRUBAKER L, WOLFE A J. The female urinary microbiota, urinary health and common urinary disorders[J]. Ann Transl Med, 2017, 5: 34.
    ARAGÓN I M, HERRERA-IMBRODA B, QUEIPO-ORTUÑO M I, et al. The urinary tract microbiome in health and disease[J]. Eur Urol Focus, 2018, 4(1): 128-138.
    MAGISTRO G, STIEF C G. The urinary tract microbiome: the answer to all our open questions?[J]. Eur Urol Focus, 2019, 5(1): 36-38.
    WOLFE A J, TOH E, SHIBATA N, et al. Evidence of uncultivated bacteria in the adult female bladder[J]. J Clin Microbiol, 2012, 50(4): 1376-1383.
    FOUTS D E, PIEPER R, SZPAKOWSKI S, et al. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury[J]. J Transl Med, 2012, 10: 174.
    KHASRIYA R, SATHIANANTHAMOORTHY S, ISMAIL S, et al. Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms[J]. J Clin Microbiol, 2013, 51(7): 2054-2062.
    PEARCE M M, ZILLIOX M J, ROSENFELD A B, et al. The female urinary microbiome in urgency urinary incontinence[J]. Am J Obstet Gynecol, 2015, 213(3): 347. e1-347. e11.
    RAVEL J, GAJER P, ABDO Z, et al. Vaginal microbiome of reproductive-age women[J]. PNAS, 2011, 108(Supplement_1): 4680-4687.
    KINROSS J M, DARZI A W, NICHOLSON J K. Gut microbiome-host interactions in health and disease[J]. Genome Med, 2011, 3(3): 14.
    MIMEE M, CITORIK R J, LU T K. Microbiome therapeutics: Advances and challenges[J]. Adv Drug Deliv Rev, 2016, 105: 44-54.
    BRUBAKER L, WOLFE A J. The new world of the urinary microbiota in women[J]. Am J Obstet Gynecol, 2015, 213(5): 644-649.
    BAO Y, AL K F, CHANYI R M, et al. Questions and challenges associated with studying the microbiome of the urinary tract[J]. Ann Transl Med, 2017, 5(2): 33.
    NG K M, FERREYRA J A, HIGGINBOTTOM S K, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens[J]. Nature, 2013, 502(7469): 96-99.
    ISAAC S, SCHER J U, DJUKOVIC A, et al. Short- and long-term effects of oral vancomycin on the human intestinal microbiota[J]. J Antimicrob Chemother, 2017, 72(1): 128-136.
    ZHANG L, HUANG Y, ZHOU Y, et al. Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota[J]. Antimicrob Agents Chemother, 2013, 57(8): 3659-3666.
    CAI T, MAZZOLI S, MONDAINI N, et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?[J]. Clin Infect Dis, 2012, 55(6): 771-777.
    BECATTINI S, TAUR Y, PAMER E G. Antibiotic-induced changes in the intestinal microbiota and disease[J]. Trends Mol Med, 2016, 22(6): 458-478.
    SENDER R, FUCHS S, MILO R. Revised estimates for the number of human and bacteria cells in the body[J]. PLoS Biol, 2016, 14(8): e1002533.
    GILBERT J A, BLASER M J, CAPORASO J G, et al. Current understanding of the human microbiome [J]. Nat Med, 2018, 24(4): 392-400.
    GRITZ E C, BHANDARI V. The human neonatal gut microbiome: a brief review[J]. Front Pediatr, 2015, 3: 17.
    SHANNON M B, LIMEIRA R, JOHANSEN D, et al. Bladder urinary oxygen tension is correlated with urinary microbiota composition[J]. Int Urogynecol J, 2019, 30(8): 1261-1267.
    REITZER L, ZIMMERN P. Rapid growth and metabolism of UropathogenicEscherichia coliin relation to urine composition[J]. Clin Microbiol Reviews, 2019, 33(1): e00101-e00119.
    BOUATRA S, AZIAT F, MANDAL R, et al. The human urine metabolome[J]. PLoS One, 2013, 8(9): e73076.
    FORSYTH V S, ARMBRUSTER C E, SMITH S N, et al. Rapid Growth of Uropathogenic Escherichia coli during Human Urinary Tract Infection[J]. mBio, 2018, 9(2): e00186.
    HYNES W L, WALTON S L. Hyaluronidases of Gram-positive bacteria[J]. FEMS Microbiol Lett, 2000, 183(2): 201-207.
    KAWAI K, KAMOCHI R, OIKI S, et al. Probiotics in human gut microbiota can degrade host glycosaminoglycans[J]. Sci Rep, 2018, 8: 10674.
    ZúÑIGA M, MONEDERO V, YEBRA M J. Utilization of host-derived glycans by intestinal Lactobacillus and Bifidobacterium species[J]. Frontiers in Microbiology, 2018, 9: 1917.
    GILBERT N M, O'BRIEN V P, LEWIS A L. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease[J]. PLoS Pathog, 2017, 13(3): e1006238.
    PRICE T K, DUNE T, HILT E E, et al. The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms[J]. J Clin Microbiol, 2016, 54(5): 1216-1222.
    MOUSTAFA A, LI W Z, SINGH H, et al. Microbial metagenome of urinary tract infection[J]. Sci Rep, 2018, 8: 4333.
    MULDER M, RADJABZADEH D, HASSING R J, et al. The effect of antimicrobial drug use on the composition of the genitourinary microbiota in an elderly population[J]. BMC Microbiol, 2019, 19: 9.
    THOMAS-WHITE K, FORSTER S C, KUMAR N, et al. Culturing of female bladder bacteria reveals an interconnected urogenital microbiota[J]. Nat Commun, 2018, 9: 1557.
    STAPLETON A E, AU-YEUNG M, HOOTON T M, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection[J]. Clin Infect Dis, 2011, 52(10): 1212-1217.
    SPAULDING C N, KLEIN R D, RUER S, et al. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist[J]. Nature, 2017, 546(7659): 528-532.
    KLEIN T, ABGOTTSPON D, WITTWER M, et al. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation[J]. J Med Chem, 2010, 53(24): 8627-8641.
    CUSUMANO C K, PINKNER J S, HAN Z F, et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors[J]. Sci Transl Med, 2011, 3(109): 109ra115.
    SCHÖNEMANN W, CRAMER J, MÜHLETHALER T, et al. Improvement of aglycone π-stacking yields nanomolar to sub-nanomolar FimH antagonists[J]. ChemMedChem, 2019, 14(7): 749-757.
    JARVIS C, HAN Z F, KALAS V, et al. Antivirulence isoquinolone mannosides: optimization of the biaryl aglycone for FimH lectin binding affinity and efficacy in the treatment of chronic UTI[J]. ChemMedChem, 2016, 11(4): 367-373.
    MYDOCK-MCGRANE L, CUSUMANO Z, HAN Z F, et al. AntivirulenceC-mannosides as antibiotic-sparing, oral therapeutics for urinary tract infections[J]. J Med Chem, 2016, 59(20): 9390-9408.
    CONOVER M S, RUER S, TAGANNA J, et al. Inflammation-induced adhesin-receptor interaction provides a fitness advantage to uropathogenic E. coli during chronic infection[J]. Cell Host Microbe, 2016, 20(4): 482-492.
    KALAS V, HIBBING M E, MADDIRALA A R, et al. Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection[J]. PNAS, 2018, 115(12): E2819-E2828.
    DURAJ-THATTE A M, PRAVESCHOTINUNT P, NASH T R, et al. Modulating bacterial and gut mucosal interactions with engineered biofilm matrix proteins[J]. Sci Rep, 2018, 8: 3475.
    SMITH A L, BROWN J, WYMAN J F, et al. Treatment and prevention of recurrent lower urinary tract infections in women: a rapid review with practice recommendations[J]. J Urol, 2018, 200(6): 1174-1191.
    SCHLAGER T A, LEGALLO R, INNES D, et al. B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections[J]. J Urol, 2011, 186(6): 2359-2364.
    HAWKEY C J. COX-1 and COX-2 inhibitors[J]. Best Pract Res Clin Gastroenterol, 2001, 15(5): 801-820.
    HANNAN T J, ROBERTS P L, RIEHL T E, et al. Inhibition of cyclooxygenase-2 prevents chronic and recurrent cystitis[J]. EBioMedicine, 2014, 1(1): 46-57.
    BLEIDORN J, GÁGYOR I, KOCHEN M M, et al. Symptomatic treatment(ibuprofen)or antibiotics(ciprofloxacin)for uncomplicated urinary tract infection- Results of a randomized controlled pilot trial[J]. BMC Med, 2010, 8: 30.
    GÁGYOR I, BLEIDORN J, KOCHEN M M, et al. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial[J]. BMJ, 2015: h6544.
    KRONENBERG A, BüTIKOFER L, ODUTAYO A, et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial[J]. BMJ, 2017, 359: j4784.
    • Related Articles

  • Related Articles

    [1]PANG Hubo. Clinical effect of bronchoscopy lavage combined with antibiotics in treatment of patients with refractory pulmonary multi-drug resistant bacteria infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 19-21. DOI: 10.7619/jcmp.202003006
    [2]BAI Weili. Risk factors and nursing strategies of pulmonary infection in patients with cerebrovascular accident[J]. Journal of Clinical Medicine in Practice, 2017, (22): 13-15. DOI: 10.7619/jcmp.201722005
    [3]ZHAO Xinglan, LI Rui, YIN Na, LIU Hailing. Risk factors of indwelling catheter related urinary tract infection in department of urology and its clinical nursing prevention strategy[J]. Journal of Clinical Medicine in Practice, 2017, (20): 112-115. DOI: 10.7619/jcmp.201720036
    [4]SUN Boyu. Value of intrathecal injection of antibiotics in treatment of patients with intracranial infection after traumatic brain injury[J]. Journal of Clinical Medicine in Practice, 2017, (1): 62-64. DOI: 10.7619/jcmp.201701018
    [5]WANG Zhenyi. Application of nursing strategy in prevention of hypostatic pneumonia in craniocerebral injury patients with tracheotomy[J]. Journal of Clinical Medicine in Practice, 2016, (16): 109-111,115. DOI: 10.7619/jcmp.201616033
    [6]YU Xiufeng, LIAO Hong, WU Yunxia, HUANG Xuejun. Effect of optimized nursing strategy on the clinical efficacy of renal carcinoma patients by targeted treatment[J]. Journal of Clinical Medicine in Practice, 2016, (16): 82-85. DOI: 10.7619/jcmp.201616025
    [7]TANG Haicheng, BO Hongjian, ZHOU Zhixiang, ZHANG Qun, JIANG Yongqian, MA Da. Clinical significance of serum procalcitonin detection in antibiotic treatment of patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2013, (24): 16-19,23. DOI: 10.7619/jcmp.201324005
    [8]MIAO Chunjun, SHEN Xiaming. Clinical effect of combined small doses of sex hormone and antibiotics on female urinary tract infection after menopause[J]. Journal of Clinical Medicine in Practice, 2013, (17): 110-112. DOI: 10.7619/jcmp.201317040
    [9]MA Ping-ping, ZHOU Xiao-mei. Nursing strategy for severe surgical patients using Portland regimen of intensive insulin therapy[J]. Journal of Clinical Medicine in Practice, 2011, (18): 123-125. DOI: 10.3969/j.issn.1672-2353.2011.18.056
    [10]ZHOU Xin. New trend and treatment strategies of invasive fungal infections[J]. Journal of Clinical Medicine in Practice, 2010, (7): 1-2. DOI: 10.3969/j.issn.1672-2353.2010.07.001

  • Cited by

    Periodical cited type(3)

    1. 杨震宇，於江泉. 宏基因组二代测序诊断免疫缺陷患者感染性疾病的研究进展. 实用临床医药杂志. 2024(09): 129-133 . 本站查看
    2. 马海昀，张永栋，刘佳雯，赵璐，杨成霞，鄂芬芬，张容容，绽丽. 基于CiteSpace的国内外血液透析用水研究可视化分析. 现代医院. 2024(06): 970-976+980 .
    3. 杨雅名，史继新，王艳伟，张瑞雪，张文增. 基于中国知网1978—2024年国内流感监测研究热点与趋势的可视化分析. 中国初级卫生保健. 2024(11): 1-5 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (476) PDF downloads (40) Cited by(3)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return